Heraeus Medical Components said today that it acquired Evergreen Medical Technologies and its PhysioTest subsidiary for an undisclosed amount.
St. Paul, Minn.-based Evergreen is a contract design, development and manufacturing consultant that specializes in neuromodulation technologies, including implantable leads and stimulation devices.
“With over 600 diseases of the nervous system, neuromodulation will be an increasingly important treatment option to improve patients’ quality of life. We continue to expand our capabilities in neuromodulation to support our medical device customers, and with this acquisition we will enable our customers to accelerate innovation in this therapy area,” Heraeus Medical Components president Nicolas Guggenheim said in prepared remarks.
“The combined strengths of our two organizations will help medical device companies to further streamline their supply chains, bring cost-effective solutions to market faster and, most importantly, be clinically effective.”
Minneapolis-based Heraeus, a vertically integrated solutions provider for the medtech industry, acquired acquiring conductive polymer materials maker Biotectix in September 2017. Earlier this year the company opened a new manufacturing facility in Costa Rica for manufacturing guidewires.